Literature DB >> 6156906

Sequential metabolic expressions of the lethal process in human serum-treated Escherichia coli: role of lysozyme.

R J Martinez, S F Carroll.   

Abstract

Several metabolic parameters indicative of Escherichia coli function and integrity were kinetically examined in response to treatment with normal human serum in the presence and absence of functional human lysozyme. Specific inhibition of this enzyme in bacteriolytic and bactericidal reactions was accomplished by using purified rabbit anti-human lysozyme immunoglobulin G. Initiation of the complement-mediated alterations of cytoplasmic membrane integrity, as judged by the leakage of 86Rb from prelabeled cells or the hydrolysis of o-nitrophenyl-beta-D-galactopyranoside by a cryptic strain, was found to be independent of lysozyme action. Furthermore, inhibition of macromolecular synthesis by E. coli in response to serum treatment occurred at the same time regardless of the functional state of lysozyme. Although the rate and extent of bacteriolysis were reduced in the absence of lysozyme, the bactericidal kinetics was unaffected. These results demonstrate that the lethal events associated with the action of antibody and complement on gram-negative bacteria are independent of lysozyme, suggesting an accessory role for this enzyme in immune reactions. A possible temporal sequence of complement-induced effects occurring at the cell surface is presented.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6156906      PMCID: PMC551012          DOI: 10.1128/iai.28.3.735-745.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  32 in total

Review 1.  Complement.

Authors:  H J Müller-Eberhard
Journal:  Annu Rev Biochem       Date:  1975       Impact factor: 23.643

2.  Electron spin resonance studies on interaction of complement proteins with erythrocyte membranes.

Authors:  C E Dahl; R P Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

3.  A kinetic study of the bacteriolytic and bactericidal action of human serum.

Authors:  A A Glynn; C M Milne
Journal:  Immunology       Date:  1967-06       Impact factor: 7.397

4.  Lysozyme and immune bacteriolysis.

Authors:  A A Glynn; C M Milne
Journal:  Nature       Date:  1965-09-18       Impact factor: 49.962

5.  Bactericidal properties of human cell-free lymph.

Authors:  R J Martinez
Journal:  Infect Immun       Date:  1976-03       Impact factor: 3.441

6.  Electrical measurements of complement-mediated membrane damage in cultured nerve and muscle cells.

Authors:  C L Stephens; P A Henkart
Journal:  J Immunol       Date:  1979-02       Impact factor: 5.422

7.  Binding of desoxycholate, phosphatidylcholine vesicles, lipoprotein and of the S-protein to complexes of terminal complement components.

Authors:  E R Podack; H J Müller-Eberhard
Journal:  J Immunol       Date:  1978-09       Impact factor: 5.422

8.  Lysozyme: primary bactericidin in human plasma serum active against Bacillus subtilis.

Authors:  M E Selsted; R J Martinez
Journal:  Infect Immun       Date:  1978-06       Impact factor: 3.441

9.  Role of rabbit lysozyme in in vitro serum and plasma serum bactericidal reactions against Bacillus subtilis.

Authors:  S F Carroll; R J Martinez
Journal:  Infect Immun       Date:  1979-09       Impact factor: 3.441

10.  Effects of serum components on gram-negative bacteria during bactericidal reactions.

Authors:  L Melching; S I Vas
Journal:  Infect Immun       Date:  1971-01       Impact factor: 3.441

View more
  22 in total

1.  Killing of gram-negative bacteria by lactoferrin and lysozyme.

Authors:  R T Ellison; T J Giehl
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

2.  Does complement kill E. coli by producing transmural pores?

Authors:  J Born; S Bhakdi
Journal:  Immunology       Date:  1986-09       Impact factor: 7.397

Review 3.  Secretory products of macrophages.

Authors:  C F Nathan
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

4.  Determination of serum bactericidal activity with the aid of luminous bacteria.

Authors:  M Barak; S Ulitzur; D Merzbach
Journal:  J Clin Microbiol       Date:  1983-08       Impact factor: 5.948

5.  Affinity of the C9 molecule for the C5b-8 complex compared with that for the complex containing C9 molecules.

Authors:  S L MacKay; J R Dankert
Journal:  Infect Immun       Date:  1994-07       Impact factor: 3.441

6.  Inherent antibacterial activity of a peptide-based beta-hairpin hydrogel.

Authors:  Daphne A Salick; Juliana K Kretsinger; Darrin J Pochan; Joel P Schneider
Journal:  J Am Chem Soc       Date:  2007-11-07       Impact factor: 15.419

7.  Killing of Gram-negative bacteria with normal human serum and normal bovine serum: use of lysozyme and complement proteins in the death of Salmonella strains O48.

Authors:  G Bugla-Płoskońska; A Kiersnowski; B Futoma-Kołoch; W Doroszkiewicz
Journal:  Microb Ecol       Date:  2009-03-18       Impact factor: 4.552

8.  Formation of transmural complement pores in serum-sensitive Escherichia coli.

Authors:  S Bhakdi; G Kuller; M Muhly; S Fromm; G Seibert; J Parrisius
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

9.  Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity.

Authors:  R I Lehrer; A Barton; K A Daher; S S Harwig; T Ganz; M E Selsted
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

10.  Bacteriolysis of Veillonella alcalescens by lysozyme and inorganic anions present in saliva.

Authors:  M Tortosa; M I Cho; T J Wilkens; V J Iacono; J J Pollock
Journal:  Infect Immun       Date:  1981-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.